Collegium Pharmaceutical, Inc. Announces Notice of Allowance for Second DETERx(TM) Technology Patent
Published: May 20, 2010
CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO’s official communication that the Company’s application has successfully completed examination and that a patent will be issued. Once issued, this will be the second patent covering the Company’s DETERx™ platform drug delivery technology.